Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients
Status:
Not yet recruiting
Trial end date:
2027-03-01
Target enrollment:
Participant gender:
Summary
The aims of this study are to evaluate if an intensified adjuvant treatment with FOLFOXIRI
could increase the rate of cases with undetectable ct-DNA after chemotherapy and to evaluate
if a further adjuvant treatment with Trifluridine/Tipiracil could increase the rate of cases
with undetectable ct-DNA and therefore improve DFS in a population at high-risk of relapse.